CD4 Cell Count Recovery in HIV Patients Starting Treatment in Africa
Author Information
Author(s): Stephen D Lawn, Landon Myer, Linda-Gail Bekker, Robin Wood
Primary Institution: The Desmond Tutu HIV Centre, University of Cape Town
Hypothesis
Advanced pre-treatment immunodeficiency diminishes the capacity for CD4 cell count recovery during ART.
Conclusion
Patients with very low baseline CD4 counts can recover their immune function during ART, but they may take longer to reach safe CD4 levels.
Supporting Evidence
- CD4 cell counts increased from 97 cells/μl to 261 cells/μl after 48 weeks of treatment.
- 51% of patients had CD4 counts <100 cells/μl at baseline, which decreased to 4% at 48 weeks.
- Patients with baseline CD4 counts <50 cells/μl had similar rates of initial recovery compared to those with higher counts.
Takeaway
People with very low immune cells can still get better when they start treatment for HIV, but it might take them longer to feel safe and healthy.
Methodology
The study measured CD4 cell counts over 48 weeks in ART-naïve individuals starting treatment in a community-based program.
Potential Biases
Survival bias may have affected the findings, as patients with the lowest CD4 counts had a higher risk of death.
Limitations
The study only analyzed CD4 cell recovery during the first year of ART, and long-term outcomes remain undetermined.
Participant Demographics
Median age was 32 years, 75% were female, and most lived in low socioeconomic conditions.
Statistical Information
P-Value
0.007
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website